MarketPeel
Insider Trading Intelligence
Pricing
…
PB

Paul Bisaro

TXMD
DIRECTOR · THERAPEUTICSMD, INC. · CIK 0001237253
FILING MIX · LIFETIME73%/27%
BUYS
30
SELLS
11
TOTAL VALUE
$275.9K
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
190,004
AVG SELL PX
—
TRADE KIND
SHOWING 41 / 41
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 5 pending
Forward-return performance of every backtestable P/S trade by Paul Bisaro, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+6.11%-1.69%+8.59%+8.59%—
14d3+100.00%+5.93%+0.66%+4.28%+4.28%—
30d3+66.67%+8.29%+0.11%+8.19%+8.66%—
60d3(1 pending)+50.00%+31.01%+3.07%+27.95%+27.95%—
90d3(1 pending)+50.00%+3.54%+10.15%-6.61%-6.61%—
180d3(1 pending)+50.00%-25.18%+8.88%-34.05%-34.05%—
1y3(1 pending)+50.00%-33.69%+17.71%-51.40%-51.40%—
2y3(1 pending)+0.00%-86.44%+18.57%-105.01%-105.01%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TXMD · 5,000 shares · as of Sep 29, 2022
049,21698,432147,648196,86420212022SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 30 buys / 11 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
59,701——157,142Jun 4, 2026Jun 5, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASE
7,500$3.69$27.6K97,441May 14, 2026May 14, 2026 ↗View →
ZTS
ZOETIS INC.
PURCHASE
2,000$75.88$151.8K27,862May 13, 2026May 13, 2026 ↗View →
ZTS
ZOETIS INC.
PURCHASE
1,619——25,862Feb 19, 2026Feb 23, 2026 ↗View →
ZTS
ZOETIS INC.
SALE
1,619.333——0Feb 19, 2026Feb 23, 2026 ↗View →
ZTS
ZOETIS INC.
PURCHASEGRANT
Stock grant
1,936——1,936Feb 18, 2026Feb 19, 2026 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
49,796——89,941Jun 5, 2025Jun 6, 2025 ↗View →
ZTS
ZOETIS INC.
PURCHASEGRANT
Stock grant
1,596——1,596Feb 19, 2025Feb 20, 2025 ↗View →
ZTS
ZOETIS INC.
SALE
1,225.402——0Feb 8, 2025Feb 11, 2025 ↗View →
ZTS
ZOETIS INC.
PURCHASE
1,225——24,243Feb 8, 2025Feb 11, 2025 ↗View →
ZTS
ZOETIS INC.
SALE
1,236.213——0Feb 6, 2025Feb 10, 2025 ↗View →
ZTS
ZOETIS INC.
PURCHASE
1,236——23,018Feb 6, 2025Feb 10, 2025 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
15,695——40,145Jun 6, 2024Jun 7, 2024 ↗View →
ZTS
ZOETIS INC.
PURCHASE
1,463——21,782Feb 10, 2024Feb 13, 2024 ↗View →
ZTS
ZOETIS INC.
SALE
1,463.394——1,212.305Feb 10, 2024Feb 13, 2024 ↗View →
ZTS
ZOETIS INC.
PURCHASE
1,493——20,319Feb 8, 2024Feb 12, 2024 ↗View →
ZTS
ZOETIS INC.
SALE
1,493.265——0Feb 8, 2024Feb 12, 2024 ↗View →
ZTS
ZOETIS INC.
PURCHASEGRANT
Stock grant
1,223——1,223Feb 6, 2024Feb 8, 2024 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
7,575——24,450Jun 1, 2023Jun 2, 2023 ↗View →
ZTS
ZOETIS INC.
SALE
1,626.844——2,651.93Feb 11, 2023Feb 14, 2023 ↗View →
ZTS
ZOETIS INC.
PURCHASE
1,626——18,826Feb 11, 2023Feb 14, 2023 ↗View →
ZTS
ZOETIS INC.
PURCHASEGRANT
Stock grant
1,480——1,480Feb 8, 2023Feb 10, 2023 ↗View →
MYGN
MYRIAD GENETICS INC
PURCHASEGRANT
Stock grant
16,875——16,875Oct 31, 2022Nov 1, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Sep 29, 2022Oct 3, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
1,984——0Aug 18, 2022Aug 22, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
1,984——5,922Aug 18, 2022Aug 22, 2022 ↗View →
ZTS
ZOETIS INC.
PURCHASE
2,673——17,200Feb 12, 2022Feb 15, 2022 ↗View →
ZTS
ZOETIS INC.
SALE
2,673.124——4,244.815Feb 12, 2022Feb 15, 2022 ↗View →
ZTS
ZOETIS INC.
PURCHASEGRANT
Stock grant
1,192——6,917.939Feb 8, 2022Feb 10, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
50,000$0.79$39.5K196,864Aug 16, 2021Aug 18, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
96,864——146,864Aug 10, 2021Aug 12, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
96,864——0Aug 10, 2021Aug 12, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
99,174——99,174Jul 1, 2021Jul 2, 2021 ↗View →
ZTS
ZOETIS INC.
PURCHASE
2,779——14,527Feb 13, 2021Feb 17, 2021 ↗View →
ZTS
ZOETIS INC.
SALE
2,779.146——5,694.57Feb 13, 2021Feb 17, 2021 ↗View →
ZTS
ZOETIS INC.
PURCHASEGRANT
Stock grant
1,431——8,473.716Feb 10, 2021Feb 12, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
96,864——96,864Jun 18, 2020Jun 19, 2020 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
50,000$1.14$57.0K50,000Jun 4, 2020Jun 8, 2020 ↗View →
ZTS
ZOETIS INC.
PURCHASE
3,704——11,748Feb 14, 2020Feb 19, 2020 ↗View →
ZTS
ZOETIS INC.
SALE
3,704.698——7,002.829Feb 14, 2020Feb 19, 2020 ↗View →
ZTS
ZOETIS INC.
PURCHASEGRANT
Stock grant
1,596——10,707.526Feb 11, 2020Feb 13, 2020 ↗View →
Other insiders · TXMD
Loading peer insiders…
About this filer
CIK 0001237253
ROLE
Director
PRIMARY
TXMD
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001237253DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback